The Medical Imaging & Technology Alliance (MITA), the Council on Radionuclides and Radiopharmaceuticals (CORAR) Inc., and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announce that 123 organizations have expressed their support for the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (H.R. 1199/S. 1544).
Support for the FIND Act of 2023 comes from a diverse range of organizations, including patient advocacy groups, medical societies, and industry leaders, association leaders say. The legislation is also being considered on Tuesday, September 19, in a House Energy & Commerce Health Subcommittee hearing on improving seniors’ access to innovative drugs, medical devices, and technology.
Diagnostic radiopharmaceuticals enable clinicians to diagnose and treat a wide variety of life-threatening conditions, such as Alzheimer’s and Parkinson’s disease, breast and prostate cancer, heart disease, and neuroendocrine tumors, according to MITA officials. Unfortunately, Medicare currently bundles payments for this life-saving technology, creating access barriers for patients who need nuclear medicine procedures, they add.
“It’s thrilling to see such widespread support for the FIND Act of 2023,” adds Patrick Hope, executive director of MITA. “This legislation will help ensure that more patients have access to the latest nuclear medicine innovations and technologies.”
Helen Nadel, President of the SNMMI, also spoke out about the legislation, commenting: “We are proud to stand alongside more than 100 organizations in support of the FIND Act, which will help ensure that patients have access to the latest diagnostic nuclear medicine procedures and technologies,” says Helen Nadel, president of the SNMMI.
Finally, Ali Manson, vice president of government relations and advocacy for ZERO Prostate Cancer, emphasized the need for advanced testing and imaging to accurately diagnose and evaluate prostate cancer progression and treatment outcomes in men. “It is time for Congress to expand access to these procedures and address flawed payment policy through passage of the FIND Act,” Manson adds.
